CCAP

Crescent Capital BDC, Inc. faces ongoing headwinds, with a 19% dividend cut following rising non-accruals and declining investment income. Despite a steep 39% discount to NAV and a 12%+ yield, I remain cautious given persistent inflation and the potential for further downside. CCAP's Q1 saw net investment income drop to $0.38/share and non-accruals spike to 5.7% at cost, pressuring NAV and dividend sustainability.

ACRE, CWST and CCAP have been added to the Zacks Rank #5 (Strong Sell) List on June 16, 2026.

CCAP, DAVA and RH have been added to the Zacks Rank #5 (Strong Sell) List on June 12, 2026.

LOS ANGELES & NEW YORK & BOSTON & CHICAGO--(BUSINESS WIRE)--Crescent Capital Group LP (“Crescent”), one of the leading alternative credit investment firms, announced today the successful final close of its fourth U.S. direct lending fund, Crescent Direct Lending Fund IV (“CDL Fund IV”), raising $10.8 billion in investable capital, including targeted leverage and separately managed accounts investing alongside the fund. CDL Fund IV represents the latest vintage in Crescent's lower middle market.

There is a principle I have followed for 30 years in this business. When the smartest credit team on the planet starts aggressively buying a beaten-down asset class they understand better than anyone alive, you do not sit on your hands and debate whether the timing is perfect.

Crescent Capital BDC trades near a 52-week low, offering a 13% yield and a deep 0.61x price-to-book discount. CCAP's first-lien-heavy, diversified portfolio and recent management fee reductions support strong NII-to-dividend coverage at 113.5%. Nonaccruals rose to 3.6% of portfolio value, mainly in healthcare, but management actively manages these with meaningful control.

Crescent Capital BDC NASDAQ: CCAP reported a more difficult first quarter as higher non-accruals, lower base rates and broader credit-market volatility weighed on earnings and net asset value, prompting management to lower fees and reset the company's base dividend.

LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the first quarter ended March 31, 2026 on Wednesday, May 13, 2026 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, May 14, 2026 at 12:00 p.m. Eastern Time to discuss its first quarter ended March 31, 2026 financial results.

Declining interest rates are likely to weigh on loan yields, while demand for personalized financing is expected to rise. The Zacks SBIC & Commercial Finance industry players like MAIN and CCAP are worth investing in.

Crescent Capital BDC is downgraded to a sell due to persistent NAV declines, rising non-accruals, and weakening dividend coverage. Despite trading at a 35% discount to NAV and offering a 14.4% yield, CCAP's valuation reflects sector headwinds and limited growth opportunities. Net investment income and portfolio value have both declined year-over-year, with new investment activity sharply reduced amid high-interest rates.